---
title: van der Straten L, Stege CAM, Kersting S, etÂ al. Fixed-duration venetoclax
  plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit
  patients with CLL. Blood. 2023;142(13):1131-1142
date: '2024-07-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39023875/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240718181718&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...